Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-011674

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 8:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 15, 2018M1,548$0.00A111,286D
Common StockF1Feb 15, 2018M817$0.00A112,103D
Common StockFeb 16, 2018S1,183$46.50D110,920D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Feb 15, 2018M1,548D——Common Stock1,5480D
Restricted Stock UnitsF3,F6,F7—Feb 15, 2018M817D——Common Stock817545D

Explanation of responses